Akanocure Pharmaceuticals
West Lafayette
About Akanocure Pharmaceuticals
Metastasis is the spread of cancer to surrounding tissues and distant organs. It is responsible for 90% of cancer deaths. Medical efforts usually fail in managing the disease once it spreads through the body. Akanocure's mission is to find therapeutic approaches that block metastatic processes. The team at Akanocure is applying the expertise of its members throughout the drug discovery and development process to create novel small molecules that will positively impact the lives of cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Grant (Aug 2022)
- Website: akanocure.com
- Phone: [email protected]
Industries & Categories
Health Care, Oncology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/akanocure-pharmaceuticals-151280 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.